Shuai Lu

859 total citations
42 papers, 574 citations indexed

About

Shuai Lu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shuai Lu has authored 42 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shuai Lu's work include Cancer-related molecular mechanisms research (5 papers), Cancer, Lipids, and Metabolism (5 papers) and Ferroptosis and cancer prognosis (4 papers). Shuai Lu is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Cancer, Lipids, and Metabolism (5 papers) and Ferroptosis and cancer prognosis (4 papers). Shuai Lu collaborates with scholars based in China, United States and Australia. Shuai Lu's co-authors include Qing Su, Li Qin, Benqiang Rao, Guang Ning, Hongxia Gu, Zhaohui Wang, Zhen Yang, Yixin Niu, Xiaoyong Li and Hongmei Zhang and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Life Sciences.

In The Last Decade

Shuai Lu

36 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuai Lu China 13 197 113 106 87 76 42 574
Seyed Mostafa Parizadeh Iran 17 194 1.0× 117 1.0× 99 0.9× 76 0.9× 48 0.6× 29 682
Aleksandra Topić Serbia 13 135 0.7× 117 1.0× 64 0.6× 40 0.5× 48 0.6× 42 559
Chia‐Yuan Liu Taiwan 15 249 1.3× 71 0.6× 86 0.8× 99 1.1× 180 2.4× 40 781
Dongfang Su China 17 253 1.3× 56 0.5× 180 1.7× 121 1.4× 38 0.5× 30 809
Bin Bai China 19 245 1.2× 60 0.5× 52 0.5× 209 2.4× 73 1.0× 47 886
Zhonggao Xu China 17 312 1.6× 55 0.5× 159 1.5× 76 0.9× 53 0.7× 48 1.0k
Huanhuan Zhao China 12 157 0.8× 37 0.3× 84 0.8× 46 0.5× 44 0.6× 35 511
Zhaolin Sun China 15 193 1.0× 86 0.8× 55 0.5× 42 0.5× 83 1.1× 51 550
Zuyi Yuan China 14 287 1.5× 40 0.4× 100 0.9× 135 1.6× 47 0.6× 40 655
Antonio Ferruelo Spain 19 293 1.5× 156 1.4× 155 1.5× 42 0.5× 231 3.0× 52 865

Countries citing papers authored by Shuai Lu

Since Specialization
Citations

This map shows the geographic impact of Shuai Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuai Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuai Lu more than expected).

Fields of papers citing papers by Shuai Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuai Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuai Lu. The network helps show where Shuai Lu may publish in the future.

Co-authorship network of co-authors of Shuai Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Shuai Lu. A scholar is included among the top collaborators of Shuai Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuai Lu. Shuai Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Shuai, et al.. (2025). Targeting therapy of PI3K/AKT signaling pathway via non-coding RNAs in diabetic retinopathy. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(9). 11493–11504. 1 indexed citations
2.
Yao, Mingtao, Shijie Yu, Yi Wang, et al.. (2025). Overall and Progression-Free Survival of Patients With Malignant Neoplasm Following Intravenous Vitamin C: A Systematic Review and Meta-Analysis. International Journal for Vitamin and Nutrition Research. 95(3). 37372–37372.
3.
Lu, Shuai. (2024). Influence of propranolol plus methimazole on curative efficacy and thyroid function of patients with hyperthyroidism. American Journal of Translational Research. 16(4). 1375–1382. 2 indexed citations
4.
Wang, Bing, et al.. (2023). Prognostic value of the ascites characteristics in pseudomyxoma peritonei originating from the appendix. Frontiers in Surgery. 9. 967296–967296.
5.
Hu, Jing, Wenhu Liu, Cui Li, et al.. (2023). Exploring the pathogenesis and immune infiltration in dilated cardiomyopathy complicated with atrial fibrillation by bioinformatics analysis. Frontiers in Immunology. 14. 1049351–1049351. 8 indexed citations
6.
Hu, Jing, Li Cui, Qian Xu, et al.. (2023). Causal Association Between Anemia and Cardiovascular Disease: A 2‐Sample Bidirectional Mendelian Randomization Study. Journal of the American Heart Association. 12(12). e029689–e029689. 26 indexed citations
7.
Lu, Shuai, et al.. (2022). Molecular Targets and Mechanisms of Hedyotis diffusa-Scutellaria barbata Herb Pair for the Treatment of Colorectal Cancer Based on Network Pharmacology and Molecular Docking. Evidence-based Complementary and Alternative Medicine. 2022. 1–15. 7 indexed citations
10.
Zhang, Hongmei, Xiaoyong Li, Ning Lin, et al.. (2022). Lymphocytes ≥ 2.9 (109/L) in Newly Diagnosed Diabetes Are A Predictor of Future CVD Events. Current Medical Science. 42(2). 327–332.
11.
Lu, Shuai, et al.. (2022). Faecal microbiota transplantation is better than probiotics for tissue regeneration of type 2 diabetes mellitus injuries in mice. Archives of Physiology and Biochemistry. 130(3). 333–341. 7 indexed citations
12.
Wang, Ya, Ya Wang, Shuai Lu, et al.. (2020). Sacubitril/valsartan treatment relieved the progression of established pulmonary hypertension in rat model and its mechanism. Life Sciences. 266. 118877–118877. 13 indexed citations
13.
Zhang, Shuwen, et al.. (2018). Evaluation of Schizas morphological grading of lumbar spinal stenosis by magnetic resonance imaging. 23(1). 52–58. 1 indexed citations
14.
Wang, Xu, Shuai Lu, Ling Xu, et al.. (2018). Alteration of gene expression profile in CD3<sup>+</sup> T-cells after downregulating MALT1. ImmunoTargets and Therapy. Volume 7. 77–81. 1 indexed citations
15.
Wei, Yuzhen, Xiaofei Yan, Lianhua Yan, et al.. (2017). Inhibition of microRNA-155 ameliorates cardiac fibrosis in the process of angiotensin II-induced cardiac remodeling. Molecular Medicine Reports. 16(5). 7287–7296. 34 indexed citations
16.
Qin, Li, Zhen Yang, Weiwei Zhang, et al.. (2016). Metabolic syndrome and osteoporotic fracture: a population-based study in China. BMC Endocrine Disorders. 16(1). 27–27. 23 indexed citations
17.
Yang, Zhen, Chonghuai Yan, Gang Liu, et al.. (2016). Plasma selenium levels and nonalcoholic fatty liver disease in Chinese adults: a cross-sectional analysis. Scientific Reports. 6(1). 37288–37288. 63 indexed citations
18.
Qin, Li, Zhen Yang, Weiwei Zhang, et al.. (2015). Association between metabolic syndrome and lung function in middle-aged and elderly Chinese individuals. Diabetes Research and Clinical Practice. 108(3). e46–e48. 8 indexed citations
19.
Cai, Jian, Shuai Lu, Yao Zheng, et al.. (2014). Glibenclamide attenuates myocardial injury by lipopolysaccharides in streptozotocin-induced diabetic mice. Cardiovascular Diabetology. 13(1). 106–106. 26 indexed citations
20.
Qin, Li, Zhen Yang, Hongxia Gu, et al.. (2014). Association between serum uric acid levels and cardiovascular disease in middle-aged and elderly Chinese individuals. BMC Cardiovascular Disorders. 14(1). 26–26. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026